查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566939

生物样本库管理系统市场：依样本类型、按应用：2024-2033 年全球机会分析与产业预测

Biobank Management Systems Market By Sample Type , By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年生物样本库管理系统市场规模为21亿美元，预计2033年将达46亿美元，2024年至2033年复合年增长率为8.3%。

生物样本库管理系统是先进的平台，旨在简化管理生物样本和相关资料的复杂流程。这些系统可确保有效收集、储存和搜寻对于基因组学、个人化医疗和药物发现等各个领域的研究和开发至关重要的生物检体。除了储存管理之外，它还包括管理捐赠者的同意、处理资料隐私以及透过在最佳条件下储存样本来支援高品质研究等功能。透过自动化许多日常业务，生物样本库管理系统可以减少错误、节省时间并提高生物样本库效率，使研究人员和医疗相关人员能够更轻鬆地获得研究和临床试验所需的样本。

由于研究和个人化医疗对生物样本的需求激增，生物样本库数量不断增加，这是推动全球生物样本库管理系统市场成长的关键因素。国家生物技术资讯中心 2021 年的一项研究强调了生物样本库活动的显着增长，生物样本库的数量每年增加约 10%。随着基因组研究的扩展，对管理和组织大量生物资料和样本的复杂系统的需求不断增加，进一步推动了对生物样本库管理系统的需求。此外，快速成长的个人化医疗需求也对市场成长做出了重大贡献。这是因为个人化医疗严重依赖生物样本的采集和分析，增加了对高效生物样本库管理系统的需求。 《柳叶刀》2023 年发表的一项研究预测，由于对个人化医疗和客製化治疗的日益关注，生物样本库管理系统的采用率将增加 25%。此外，COVID-19 大流行的爆发凸显了高效生物样本库系统在管理和分配研究用生物样本方面的重要性，导致人们越来越关註生物样本库管理系统的采用，从而促进市场成长。此外，将人工智慧和机器学习技术整合到生物样本库管理系统中以增强资料分析、预测建模和自动化决策是当前的趋势，可显着促进市场成长。云端基础的生物样本库管理系统的采用正在兴起，提供可扩展的储存解决方案、改进的资料可存取性并增强研究团队之间的协作。然而，对生物样本库管理系统的好处的认识有限以及缺乏实施和维护这些系统的专业知识正在阻碍市场的成长。儘管安全措施取得了进步，但对资料外洩和未授权存取敏感生物资料的担忧阻碍了机构全面采用数位管理系统。相反，资料管理、自动化和云端运算方面的技术创新正在增强生物样本库管理系统的能力，并有望在预测期内为全球市场扩张提供利润丰厚的机会。此外，政府机构、研究机构和私人公司对生物银行和相关技术的投资不断增加，也有助于扩大生物样本库管理系统市场。

全球生物样本库管理系统产业按样本类型、应用和区域细分。依样本类型分为可吸收人体组织/器官样本、植物/动物样本和微生物样本。依应用领域分为再生医学、生命科学研究、临床研究、环境研究等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从样本类型来看，人体组织/器官样本领域在2023年占据市场主导地位。

依申请，2023年临床研究板块为大股东。

按地区划分，2023年北美占据市场主导地位。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章生物样本库管理系统市场：依样本类型

  • 市场概况
  • 可吸收人体组织器官样本
  • 植物动物样品
  • 微生物样本

第五章生物样本库管理系统市场：依应用分类

  • 市场概况
  • 再生医学
  • 生命科学研究
  • 临床研究
  • 环境调查

第六章生物样本库管理系统市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国生物样本库管理系统市场
    • 加拿大生物样本库管理系统市场
    • 墨西哥生物样本库管理系统市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国生物样本库管理系统市场
    • 法国生物样本库管理系统市场
    • 英国生物样本库管理系统市场
    • 义大利生物样本库管理系统市场
    • 西班牙生物样本库管理系统市场
    • 其他欧洲国家生物样本库管理系统市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本生物样本库管理系统市场
    • 中国生物样本库管理系统市场
    • 澳洲生物样本库管理系统市场
    • 印度生物样本库管理系统市场
    • 韩国生物样本库管理系统市场
    • 其他亚太生物样本库管理系统市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西生物样本库管理系统市场
    • 沙乌地阿拉伯生物样本库管理系统市场
    • 南非生物样本库管理系统市场
    • 其他拉丁美洲/中东/非洲生物样本库管理系统市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 有竞争力的仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Agilent Technologies, Inc.
  • CloudLIMS Technologies Pvt. Ltd.
  • AgileBio SARL
  • Modul-Bio
  • Autoscribe Informatics
  • Krishagni Solutions Pvt Ltd
  • Information Management Services, Inc
  • Technidata Inc
  • Qiagen NV
  • Azenta Inc
简介目录
Product Code: A323972

The biobank management systems market was valued at $2.1 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.

Biobank management system is an advanced platform designed to streamline the complex processes involved in managing biological samples and associated data. These systems ensure efficient collection, storage, and retrieval of biological specimens, which are essential for research and development in various fields, including genomics, personalized medicine, and drug discovery. In addition to storage management, these systems include features for managing consent from donors, handling data privacy, and supporting high-quality research by ensuring that samples are stored under optimal conditions. By automating many routine tasks, biobank management systems reduce errors, save time, and improve the efficiency of biobanks, making it easier for researchers and medical professionals to access the samples they need for studies and clinical trials.

Increase in number of biobanks, driven by surge in demand for biological samples in research and personalized medicine, is a significant factor fueling the growth of the global biobank management systems market. A study by the National Center for Biotechnology Information in 2021 highlighted that biobank activities have been growing significantly, with the number of biobanks increasing by approximately 10% annually. As genomic research expands, the need for sophisticated systems to manage and organize large volumes of biological data and samples has grown, further boosting the demand for biobank management systems. Moreover, surge in demand for personalized medicine is notably contributing toward the market growth. This is attributed to the fact that personalized medicine relies heavily on the availability and analysis of biological samples, increasing the need for efficient biobank management systems. A study published in The Lancet in 2023 projected a 25% rise in the adoption of biobank management systems due to the growing focus on personalized medicine and tailored treatments. Furthermore, the outbreak of the COVID-19 pandemic highlighted the importance of efficient biobanking systems to manage and distribute biological samples for research, which led to an increased focus on adopting biobank management systems, thereby augmenting the market growth. In addition, integration of AI and ML technologies in biobank management systems to enhance data analysis, predictive modeling, and automated decision-making is the current trend that is significantly augmenting the market growth. Adoption of cloud-based biobank management systems is on rise, offering scalable storage solutions, improved data accessibility, and enhanced collaboration among research teams, which is a key trend strengthening the market growth. However, limited awareness of the benefits of biobank management systems coupled with lack of expertise in implementing and maintaining these systems hinder the market growth. Despite advancements in security measures, concerns over data breaches and unauthorized access to sensitive biological data can deter institutions from fully adopting digital management systems. On the contrary, innovations in data management, automation, and cloud computing have enhanced the capabilities of biobank management systems, which are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. In addition, rise in investments from government bodies, research institutions, and private companies in biobanking and related technologies are contributing to the expansion of the biobank management systems market.

The global biobank management systems industry is segmented into sample type, application, and region. By sample type, the market is divided into absorbable human tissue & organ samples, plant & animal samples, and microbial samples. On the basis of application, it is classified into regenerative medicine, life science research, clinical research, and environmental research. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By sample type, the human tissue & organ samples segment dominated the market, in terms of share, in 2023.

On the basis of application, the clinical research segment was the major shareholder in 2023.

Region wise, North America held the leading position in the market in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global biobank management systems market include Agilent Technologies, Inc., CloudLIMS Technologies Pvt. Ltd., AgileBio SARL, Modul-Bio, Autoscribe Informatics, Krishagni Solutions Pvt Ltd., Information Management Services, Inc, Technidata Inc, Qiagen N.V, and Azenta Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Sample Type

  • Absorbable Human Tissue Organ Samples
  • Plant Animal Samples
  • Microbial Samples

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
  • Environmental Research

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Agilent Technologies, Inc.
    • CloudLIMS Technologies Pvt. Ltd.
    • AgileBio SARL
    • Modul-Bio
    • Autoscribe Informatics
    • Krishagni Solutions Pvt Ltd
    • Information Management Services, Inc
    • Technidata Inc
    • Qiagen N.V
    • Azenta Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOBANK MANAGEMENT SYSTEMS MARKET, BY SAMPLE TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Sample Type
  • 4.2. Absorbable Human Tissue Organ Samples
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Plant Animal Samples
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Microbial Samples
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOBANK MANAGEMENT SYSTEMS MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Regenerative Medicine
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Life Science Research
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Clinical Research
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Environmental Research
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOBANK MANAGEMENT SYSTEMS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Sample Type
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Biobank Management Systems Market
      • 6.2.5.1. Market Size and Forecast, By Sample Type
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Biobank Management Systems Market
      • 6.2.6.1. Market Size and Forecast, By Sample Type
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Biobank Management Systems Market
      • 6.2.7.1. Market Size and Forecast, By Sample Type
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Sample Type
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Biobank Management Systems Market
      • 6.3.5.1. Market Size and Forecast, By Sample Type
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. France Biobank Management Systems Market
      • 6.3.6.1. Market Size and Forecast, By Sample Type
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. UK Biobank Management Systems Market
      • 6.3.7.1. Market Size and Forecast, By Sample Type
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Italy Biobank Management Systems Market
      • 6.3.8.1. Market Size and Forecast, By Sample Type
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. Spain Biobank Management Systems Market
      • 6.3.9.1. Market Size and Forecast, By Sample Type
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Biobank Management Systems Market
      • 6.3.10.1. Market Size and Forecast, By Sample Type
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Sample Type
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Biobank Management Systems Market
      • 6.4.5.1. Market Size and Forecast, By Sample Type
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. China Biobank Management Systems Market
      • 6.4.6.1. Market Size and Forecast, By Sample Type
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. Australia Biobank Management Systems Market
      • 6.4.7.1. Market Size and Forecast, By Sample Type
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. India Biobank Management Systems Market
      • 6.4.8.1. Market Size and Forecast, By Sample Type
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. South Korea Biobank Management Systems Market
      • 6.4.9.1. Market Size and Forecast, By Sample Type
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Biobank Management Systems Market
      • 6.4.10.1. Market Size and Forecast, By Sample Type
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Sample Type
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Biobank Management Systems Market
      • 6.5.5.1. Market Size and Forecast, By Sample Type
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. Saudi Arabia Biobank Management Systems Market
      • 6.5.6.1. Market Size and Forecast, By Sample Type
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. South Africa Biobank Management Systems Market
      • 6.5.7.1. Market Size and Forecast, By Sample Type
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Biobank Management Systems Market
      • 6.5.8.1. Market Size and Forecast, By Sample Type
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Agilent Technologies, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. CloudLIMS Technologies Pvt. Ltd.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. AgileBio SARL
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Modul-Bio
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Autoscribe Informatics
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Krishagni Solutions Pvt Ltd
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Information Management Services, Inc
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Technidata Inc
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Qiagen N.V
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Azenta Inc
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments